A. Tailleux et al., Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice, ART THROM V, 20(11), 2000, pp. 2453-2458
Studies performed in vivo have been controversial regarding the implication
of human apolipoprotein (apo)A-II in the atherogoenic process. Expression
of human apoA-II in transgenic mice fed a chow diet leads to (1) a bimodal
distribution of high density lipoprotein (HDL) size as in humans, (2) a red
uction in total cholesterol concentration that is mainly due to a reduction
in non-HDL cholesterol level, and (3) a dramatic reduction in mouse endoge
nous apoA-I and apoA-II. After 20 weeks on an atherogenic diet, transgenic
mice had reduced total cholesterol concentrations because of a reduction in
cholesterol associated with all lipoprotein classes. Endogenous apoA-I and
apoA-II were also dramatically decreased in transgenic mice. The mean area
of atherosclerotic lesions was drastically decreased in transgenic mice (-
44%, P=0.0027) compared with control mice. The amount of aortic surface cov
ered by lesions was positively correlated with very low density lipoprotein
cholesterol (P<0.01) and intermediate density lipoprotein cholesterol leve
ls (P<0.05). Transgenic mice were protected against the development of athe
rosclerosis despite a marked decrease in HDL cholesterol and apoA-I concent
rations. This protection may be related to the marked reduction in circulat
ing low density lipoprotein (very low density and intermediate density lipo
protein) levels in transgenic mice.